Biblio

Found 16 results
Filters: Keyword is Disease Progression  [Clear All Filters]
2018
Fowler EG, Staudt LA, Heberer KR, Sienko SE, Buckon CE, Bagley AM, Sussman MD, McDonald CM.  2018.  Longitudinal Community Walking Activity in Duchenne Muscular Dystrophy.. Muscle Nerve. 57(3):401-406.
2016
Diniz-Filho A, Abe RY, Cho HJin, Baig S, Gracitelli CPB, Medeiros FA.  2016.  Fast Visual Field Progression Is Associated with Depressive Symptoms in Patients with Glaucoma.. Ophthalmology. 123(4):754-9.
2015
Davis LZ, Slavich GM, Thaker PH, Goodheart MJ, Bender DP, Dahmoush L, Farley DM, Markon KE, Penedo FJ, Lubaroff DM et al..  2015.  Eudaimonic well-being and tumor norepinephrine in patients with epithelial ovarian cancer.. Cancer. 121(19):3543-50.
Lamkin DM, Sung HYeon, Yang GSik, David JM, C Y Ma J, Cole SW, Sloan EK.  2015.  α2-Adrenergic blockade mimics the enhancing effect of chronic stress on breast cancer progression.. Psychoneuroendocrinology. 51:262-70.
2014
Kim-Fuchs C, Le CP, Pimentel MA, Shackleford D, Ferrari D, Angst E, Hollande F, Sloan EK.  2014.  Chronic stress accelerates pancreatic cancer growth and invasion: a critical role for beta-adrenergic signaling in the pancreatic microenvironment.. Brain Behav Immun. 40:40-7.
2013
Chai MG, Kim-Fuchs C, Angst E, Sloan EK.  2013.  Bioluminescent orthotopic model of pancreatic cancer progression.. J Vis Exp. (76)
Le CP, Karnezis T, Achen MG, Stacker SA, Sloan EK.  2013.  Lymphovascular and neural regulation of metastasis: shared tumour signalling pathways and novel therapeutic approaches.. Best Pract Res Clin Anaesthesiol. 27(4):409-25.
Armaiz-Pena GN, Cole SW, Lutgendorf SK, Sood AK.  2013.  Neuroendocrine influences on cancer progression.. Brain Behav Immun. 30 Suppl:S19-25.
Kurita K, Garon EB, Stanton AL, Meyerowitz BE.  2013.  Uncertainty and psychological adjustment in patients with lung cancer.. Psychooncology. 22(6):1396-401.
2012
Lamkin DM, Sloan EK, Patel AJ, Chiang BS, Pimentel MA, C Y Ma J, Arevalo JM, Morizono K, Cole SW.  2012.  Chronic stress enhances progression of acute lymphoblastic leukemia via β-adrenergic signaling.. Brain Behav Immun. 26(4):635-41.
Karpouzas GA, Dolatabadi S, Moran R, Li N, Nicassio PM, Weisman MH.  2012.  Correlates and predictors of disability in vulnerable US Hispanics with rheumatoid arthritis.. Arthritis Care Res (Hoboken). 64(9):1274-81.
2009
Armaiz-Pena GN, Lutgendorf SK, Cole SW, Sood AK.  2009.  Neuroendocrine modulation of cancer progression.. Brain Behav Immun. 23(1):10-5.
2008
Cole SW.  2008.  Psychosocial influences on HIV-1 disease progression: neural, endocrine, and virologic mechanisms.. Psychosom Med. 70(5):562-8.
2007
Irwin MR.  2007.  Depression and risk of cancer progression: an elusive link.. J Clin Oncol. 25(17):2343-4.
Thannickal TC, Lai Y-Y, Siegel JM.  2007.  Hypocretin (orexin) cell loss in Parkinson's disease.. Brain. 130(Pt 6):1586-95.
Nilsson MB, Armaiz-Pena G, Takahashi R, Lin YG, Trevino J, Li Y, Jennings N, Arevalo J, Lutgendorf SK, Gallick GE et al..  2007.  Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanism.. J Biol Chem. 282(41):29919-26.